SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-20-000129
Filing Date
2020-10-22
Accepted
2020-10-22 07:00:29
Documents
17
Period of Report
2020-10-22
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K optn-20201022.htm   iXBRL 8-K 45582
2 EX-99.1 pressreleasepreearning.htm EX-99.1 13200
8 GRAPHIC image1.jpg GRAPHIC 21492
9 GRAPHIC optn-20201022_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-20-000129.txt   269756

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20201022.xsd EX-101.SCH 2423
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT optn-20201022_cal.xml EX-101.CAL 710
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT optn-20201022_def.xml EX-101.DEF 1643
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20201022_lab.xml EX-101.LAB 25998
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20201022_pre.xml EX-101.PRE 13731
10 EXTRACTED XBRL INSTANCE DOCUMENT optn-20201022_htm.xml XML 11740
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 201251639
SIC: 2834 Pharmaceutical Preparations